Download presentation
Presentation is loading. Please wait.
1
Volume 63, Issue 3, Pages 1051-1057 (March 2003)
High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease Liam F. Casserly, Amit Fadia, Vaishali Sanchorawala, David C. Seldin, Daniel G. Wright, Martha Skinner, Laura M. Dember Kidney International Volume 63, Issue 3, Pages (March 2003) DOI: /j x Copyright © 2003 International Society of Nephrology Terms and Conditions
2
Figure 1 Survival from time of treatment of end-stage renal disease (ESRD) patients compared with non-ESRD patients (P = 0.1 by log-rank test). Kidney International , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.